Circulating Cell-Free DNA as Inflammatory Marker in Egyptian Psoriasis Patients
Haneya AA Anani,1 Amany M Tawfeik,1 Soheir S Maklad,1 Abeer M Kamel,2 Enas E El-Said,3 Asmaa S Farag2 1Departments of Microbiology and Immunology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt; 2Dermatology Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egy...
Guardado en:
Autores principales: | Anani HAA, Tawfeik AM, Maklad SS, Kamel AM, El-Said EE, Farag AS |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f6dcf878d8414c65acd84e901c4972f9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab
por: Aline Lissa Okita, et al.
Publicado: (2020) -
Spotlight on itolizumab in the treatment of psoriasis – current perspectives from India
por: Budamakuntla L, et al.
Publicado: (2019) -
Pustular psoriasis: pathophysiology and current treatment perspectives
por: Benjegerdes KE, et al.
Publicado: (2016) -
Dermoscopic hemorrhagic dots: an early predictor of response of psoriasis to biologic agents
por: Aimilios Lallas, et al.
Publicado: (2016) -
Updates on the Treatment of Erythrodermic Psoriasis
por: Lo Y, et al.
Publicado: (2021)